Conflict of interest: Nothing to declare.
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia
Version of Record online: 12 FEB 2014
© 2014 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 61, Issue 7, pages 1289–1294, July 2014
How to Cite
McGuinn, C., Geyer, M. B., Jin, Z., Garvin, J. H., Satwani, P., Bradley, M. B., Bhatia, M., George, D., Duffy, D., Morris, E., van de Ven, C., Schwartz, J., Baxter-Lowe, L. A. and Cairo, M. S. (2014), Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia. Pediatr. Blood Cancer, 61: 1289–1294. doi: 10.1002/pbc.24976
- Issue online: 2 MAY 2014
- Version of Record online: 12 FEB 2014
- Manuscript Accepted: 16 JAN 2014
- Manuscript Received: 6 SEP 2013
- Pediatric Cancer Research Foundation (PCRF)
- Brittany Barron Fund
- Marisa Fund
- Paul Luisi Foundation
Additional Supporting Information may be found in the online version of this article.
|pbc24976-sm-0001-SuppFig-S1.TIF||232K||Fig. S1. A: Cumulative probability of development of Grades II–IV Acute GVHD by Kaplan–Meier method. B: Cumulative probability of development of chronic GHVD.|
|pbc24976-sm-0001-PBC-13-1160_SuppTab-S1.docx||16K||Table S1. Predictors of Grades II–IV Acute GVHD|
|pbc24976-sm-0001-PBC-13-1160_SuppTab-S2.docx||15K||Table S2. Infections by Conditioning Regimen|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.